We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.51 | 3.02 | 4.00 | - | 8,136 | 08:00:22 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.80 | 10.36M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 29/12/2022 10:13 | ...who also has the company over a barrel financially. Hence the continuing impasse. | bluemango | |
| 29/12/2022 10:05 | You might be looking through the wrong end of the telescope, pev. The one constant through 20+ years of underperformance has been CJP. | jeffian | |
| 23/12/2022 11:36 | Another year of zero shareholder value,No stroke,No AD progress,No Single cell launch,despite reporting Y/E launch,but never mind,we are used to failure,Merry Christmas all. | peverill | |
| 23/12/2022 11:27 | Any new kitchens this year? Is it the 20th anniversary year? | dominiccummings | |
| 22/12/2022 17:35 | Otherwise known as the Ministry for Misinformation. | monte1 | |
| 22/12/2022 16:55 | I see the email ring is alive and kicking!!!!!! | peverill | |
| 22/12/2022 13:30 | A bleater blocker? | james japp | |
| 22/12/2022 13:01 | goatherd, you need a beta-blocker. | small crow | |
| 22/12/2022 12:48 | I hear that a priced for the stroke test, clinical version (which is the same product as the research version) has now been set. Certainly a step forward! | goatherd | |
| 22/12/2022 12:48 | I hear that a priced for the stroke test, clinical version (which is the same product as the research version) has now been set. Certainly a step forward! | goatherd | |
| 22/12/2022 05:20 | Neither did Theranos in the big scheme of things. | peverill | |
| 21/12/2022 13:22 | This POS couldnt tell Theranos from Therelbow. | james japp | |
| 21/12/2022 13:09 | PRM could be the AIM Theranos,but at least Lizzie had the shareprice through the roof. | peverill | |
| 21/12/2022 08:17 | Good man Denis tuchel. | james japp | |
| 20/12/2022 18:57 | MK £11M ???? Why? There is nothing, not even money for R&D and massive obligations regarding debt. There is no chance of recovery. | mashman | |
| 20/12/2022 15:02 | Good afternoon, The Bell. | james japp | |
| 20/12/2022 14:49 | Every day for the last 20 years, I check for 7am rns's. Last one was for share options, should be more about resignations | the bull | |
| 20/12/2022 11:28 | It looks like another year of non-delivery, albeit I do expect revenues to have increased again when we get the FY22 numbers. I do think the Board need to realistically review the long-term viability of the company & the ability to create shareholder value. So far the jury remains out on both counts! | wrighty41 | |
| 19/12/2022 10:40 | Good man Geraldine 455. | tom barnaby |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
